P
Description
Pharmadax (stock: 4191), founded in 2008 in New Taipei City, Taiwan, is a specialty pharmaceutical company developing and manufacturing controlled-release generic medicines and modified-release oral pellets. With 80 employees, it operates in Taiwan, the US, and China, focusing on technically complex modified-release formulations with high barriers to competition.